INTERLEUKIN-6 CAN PRIME THP-1 MACROPHAGES FOR ENHANCED PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA IN RESPONSE TO LPS

被引:13
作者
COCHRAN, FR [1 ]
FINCHARIETTA, MB [1 ]
机构
[1] HOFFMANN LA ROCHE INC,DEPT ALLERGY & INFLAMMAT,NUTLEY,NJ 07110
来源
IMMUNOPHARMACOLOGY | 1992年 / 23卷 / 02期
关键词
INTERLEUKIN-6; TUMOR NECROSIS FACTOR-ALPHA; MACROPHAGE;
D O I
10.1016/0162-3109(92)90033-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although interferon-gamma has been shown to effectively prime macrophages for enhanced production of tumor necrosis factor-alpha (TNF-alpha), it is reasonable to assume that other cytokines present in the extracellular environment may likewise facilitate cytokine biosynthesis. For example, interleukin-6 (IL-6) is synthesized by synovial lining macrophages and fibroblasts, and has been detected (along with TNF-alpha) in rheumatoid synovial effusions. Therefore, the purpose of the present study was to determine whether IL-6 influences the production of IL-1-beta and/or TNF-alpha by THP-1 macrophages. Although IL-6 treatment alone resulted in only a slight increase in TNF-alpha levels, administration of IL-6 followed by Sal. minnesota LPS resulted in a synergistic potentiation of TNF-alpha production by THP-1 macrophages. The priming effect of IL-6 could be reversed by boiling, or by the addition of a neutralizing polyclonal antibody against IL-6. Notably, IL-6 only weakly enhanced interleukin-1-beta production. In summary, the ability of IL-6 to potentiate TNF-alpha production by THP-1 macrophages may provide insight into the regulation of the cytokine network in inflammatory diseases, such as rheumatoid arthritis.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 38 条
[31]   DETECTION OF TUMOR NECROSIS FACTOR-ALPHA BUT NOT TUMOR NECROSIS FACTOR-BETA IN RHEUMATOID-ARTHRITIS SYNOVIAL-FLUID AND SERUM [J].
SAXNE, T ;
PALLADINO, MA ;
HEINEGARD, D ;
TALAL, N ;
WOLLHEIM, FA .
ARTHRITIS AND RHEUMATISM, 1988, 31 (08) :1041-1045
[32]   DEVELOPMENTAL REGULATION OF THE CYTOKINE REPERTOIRE IN HUMAN MACROPHAGES - IL-1, IL-6, TNF-ALPHA, AND M-CSF [J].
SCHEIBENBOGEN, C ;
ANDREESEN, R .
JOURNAL OF LEUKOCYTE BIOLOGY, 1991, 50 (01) :35-42
[33]  
SCHINDLER R, 1990, BLOOD, V75, P40
[34]   RECEPTORS FOR B-CELL STIMULATORY FACTOR-II - QUANTITATION, SPECIFICITY, DISTRIBUTION, AND REGULATION OF THEIR [J].
TAGA, T ;
KAWANISHI, Y ;
HARDY, RR ;
HIRANO, T ;
KISHIMOTO, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (04) :967-981
[35]   TUMOR-NECROSIS-FACTOR IN SERUM AND SYNOVIAL-FLUID OF PATIENTS WITH ACTIVE AND SEVERE RHEUMATOID-ARTHRITIS [J].
TETTA, C ;
CAMUSSI, G ;
MODENA, V ;
DIVITTORIO, C ;
BAGLIONI, C .
ANNALS OF THE RHEUMATIC DISEASES, 1990, 49 (09) :665-667
[36]   ESTABLISHMENT AND CHARACTERIZATION OF A HUMAN ACUTE MONOCYTIC LEUKEMIA-CELL LINE (THP-1) [J].
TSUCHIYA, S ;
YAMABE, M ;
YAMAGUCHI, Y ;
KOBAYASHI, Y ;
KONNO, T ;
TADA, K .
INTERNATIONAL JOURNAL OF CANCER, 1980, 26 (02) :171-176
[37]  
TSUCHIYA S, 1982, CANCER RES, V42, P1530
[38]   CHARACTERISTICS OF TUMOR NECROSIS FACTOR PRODUCTION IN RHEUMATOID-ARTHRITIS [J].
YOCUM, DE ;
ESPARZA, L ;
DUBRY, S ;
BENJAMIN, JB ;
VOLZ, R ;
SCUDERI, P .
CELLULAR IMMUNOLOGY, 1989, 122 (01) :131-145